New strategy aims to cut heart risks in diabetes patients
NCT ID NCT04866667
First seen Apr 20, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This study screened 316 people with type 2 diabetes who were at high risk for heart disease. Researchers tested whether a drug called liraglutide could help prevent new heart problems like chest pain, stroke, or heart attack. The goal was to find better ways to manage both diabetes and heart health together.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhejiang provincial people's hospital
Hangzhou, Zhejiang, 310014, China
Conditions
Explore the condition pages connected to this study.